|
RS50101B
(sr)
|
1996-02-24 |
2009-01-22 |
Boehringer Ingelheim International Gmbh., |
Farmaceutski preparati za imunomodulaciju
|
|
DE19803453A1
(de)
*
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
ATE365050T1
(de)
*
|
1998-02-25 |
2007-07-15 |
Us Gov Sec Army |
Verwendung von hautpenetrationsförderern und für die zerstörung der oberen hautschichten geeigneten mitteln zur erhöhung der transkutanen immunantwort
|
|
CA2325818C
(en)
*
|
1998-04-20 |
2008-09-02 |
Torrey Pines Institute For Molecular Studies |
Topical immunostimulation to induce langerhans cell migration
|
|
ES2572834T3
(es)
*
|
1999-02-17 |
2016-06-02 |
Csl Limited |
Complejos inmunogénicos y métodos relacionados con los mismos
|
|
DE19909503A1
(de)
*
|
1999-03-04 |
2000-09-07 |
Boehringer Ingelheim Int |
Tumorassoziiertes Antigen
|
|
US6809179B1
(en)
|
1999-08-04 |
2004-10-26 |
Boehringer Ingelheim International Gmbh |
Tumor-associated antigen (R11)
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT409762B
(de)
*
|
2000-04-13 |
2002-11-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung von zytokin sekretierenden zellen
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
KR20020014459A
(ko)
*
|
2000-08-18 |
2002-02-25 |
서진호 |
양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
|
|
JP2004519453A
(ja)
*
|
2001-01-05 |
2004-07-02 |
インターツェル・アクチェンゲゼルシャフト |
ポリカチオン性化合物の用途
|
|
WO2002053184A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Intercell Ag |
Uses for polycationic compounds as vaccine adjuvants
|
|
US7244438B2
(en)
|
2001-01-05 |
2007-07-17 |
Intercell Ag |
Uses for polycationic compounds
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
AU2002358616A1
(en)
*
|
2001-12-07 |
2003-06-17 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
US20050221350A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
WO2004011650A2
(en)
|
2002-07-24 |
2004-02-05 |
Intercell Ag |
Antigens encoded by alternative reading frame from pathogenic viruses
|
|
WO2004024182A2
(en)
|
2002-09-13 |
2004-03-25 |
Intercell Ag |
Method for isolating hepatitis c virus peptides
|
|
JP5116971B2
(ja)
|
2002-10-15 |
2013-01-09 |
インターセル アーゲー |
Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
|
|
EP2287315A1
(en)
|
2003-03-04 |
2011-02-23 |
Intercell AG |
Streptococcus pyogenes antigens
|
|
EP1608402B1
(en)
|
2003-03-24 |
2010-10-20 |
Intercell AG |
Improved vaccines
|
|
JP2007523609A
(ja)
|
2003-03-31 |
2007-08-23 |
インターツェル・アクチェンゲゼルシャフト |
表皮ブドウ球菌抗原
|
|
EP2311988A1
(en)
|
2003-04-15 |
2011-04-20 |
Intercell AG |
S. pneumoniae antigens
|
|
EP2289907A3
(en)
|
2003-05-07 |
2011-08-31 |
Intercell AG |
Streptococcus agalactiae antigens I + II
|
|
US20080175856A1
(en)
|
2003-05-30 |
2008-07-24 |
Intercell Ag |
Enterococcus Antigens
|
|
JP4734241B2
(ja)
|
2003-07-11 |
2011-07-27 |
インターツェル・アクチェンゲゼルシャフト |
Ｈｃｖワクチン
|
|
US20080145383A1
(en)
|
2004-03-12 |
2008-06-19 |
Intercell Ag |
Method for Solubilizing Peptide Mixtures
|
|
DE102004038134B4
(de)
|
2004-08-05 |
2013-07-25 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
EP2149583B1
(en)
|
2004-09-24 |
2015-10-28 |
Novartis AG |
Modified VP1-capsid protein of parvovirus B19
|
|
DE602005015605D1
(de)
*
|
2004-10-29 |
2009-09-03 |
Intercell Ag |
Hcv impfstoff für chronische hcv patienten
|
|
JP5050144B2
(ja)
|
2005-04-20 |
2012-10-17 |
満 明石 |
アジュバントとしてのポリアミノ酸
|
|
EP1887084A1
(en)
*
|
2006-08-10 |
2008-02-13 |
International Investment and Patents SA |
Plasmids with immunological action
|
|
JP2010503384A
(ja)
|
2006-09-15 |
2010-02-04 |
インターセル アーゲー |
ボレリア（Ｂｏｒｒｅｌｉａ）抗原
|
|
JP2008174490A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
抗原性ペプチドを主成分とする薬剤
|
|
CN102015754A
(zh)
|
2007-05-02 |
2011-04-13 |
英特塞尔股份公司 |
克雷伯菌（Klebsiella）抗原
|
|
KR100748265B1
(ko)
*
|
2007-06-15 |
2007-08-10 |
(주)성문엔지니어링 |
공동주택에 배선된 전선의 합선방지구조
|
|
CN101883782A
(zh)
|
2007-06-18 |
2010-11-10 |
英特塞尔股份公司 |
衣原体抗原
|
|
EA017887B1
(ru)
|
2007-08-02 |
2013-03-29 |
Байондвакс Фармасьютикалз Лтд. |
Полимерные мультиэпитопные вакцины против гриппа
|
|
CN103083643B
(zh)
*
|
2008-03-27 |
2015-01-07 |
雀巢产品技术援助有限公司 |
增加肽、肽模拟物和其他胃肠道转运蛋白底物吸收的方法
|
|
BRPI0922132A2
(pt)
|
2008-12-03 |
2018-10-23 |
Protea Vaccine Tech Ltd |
fragmentos glutamil trna sintetase (gts).
|
|
EP2405938A2
(en)
|
2009-02-13 |
2012-01-18 |
Intercell AG |
Nontypable haemophilus influenzae antigens
|
|
EP2470205A1
(en)
*
|
2009-08-27 |
2012-07-04 |
Novartis AG |
Adjuvant comprising aluminium, oligonucleotide and polycation
|
|
CN102695501A
(zh)
|
2009-11-09 |
2012-09-26 |
聚光灯技术合伙有限责任公司 |
碎裂水凝胶
|
|
CN106913902A
(zh)
|
2009-11-09 |
2017-07-04 |
聚光灯技术合伙有限责任公司 |
多糖基水凝胶
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
WO2011101465A1
(en)
|
2010-02-19 |
2011-08-25 |
Intercell Ag |
Ic31 nanoparticles
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
RU2478399C2
(ru)
*
|
2011-06-16 |
2013-04-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) |
Способ получения специфического иммуномодулятора
|
|
US20140271723A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Saint Louis University |
Adjuvant compositions and methods of using thereof
|
|
EP3925968A3
(en)
|
2014-10-07 |
2022-03-02 |
Cytlimic Inc. |
Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
|
|
EA201792501A1
(ru)
|
2015-05-13 |
2018-10-31 |
Эйдженус Инк. |
Вакцины для лечения и профилактики рака
|
|
KR101850417B1
(ko)
*
|
2015-12-16 |
2018-04-20 |
주식회사 휴벳바이오 |
스쿠알렌을 포함하는 양친매성 폴리 아미노산 고분자 기반 백신 면역보조제 조성물
|
|
JP6710004B2
(ja)
*
|
2016-03-15 |
2020-06-17 |
Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 |
免疫療法のためのモニタリングまたは診断ならびに治療剤の設計
|
|
CN109890408A
(zh)
*
|
2016-05-27 |
2019-06-14 |
埃特彼塞斯公司 |
新表位疫苗组合物及其使用方法
|
|
US11291718B2
(en)
|
2016-10-11 |
2022-04-05 |
Cytlimic Inc. |
Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
|
|
CN107469067B
(zh)
*
|
2017-09-05 |
2018-06-19 |
浙江大学 |
一种多肽及其改造体在制备免疫调节药物中的应用
|
|
MA52363A
(fr)
|
2018-04-26 |
2021-03-03 |
Agenus Inc |
Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation
|
|
CN110870913A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
|
|
CN110870912A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用
|
|
CN117860879A
(zh)
*
|
2024-01-10 |
2024-04-12 |
广州医科大学附属肿瘤医院 |
一种纳米疫苗递送系统及其制备方法和应用
|